Supernus Pharmaceuticals (SUPN) Insider Trading & Ownership $45.37 +0.30 (+0.67%) Closing price 04:00 PM EasternExtended Trading$45.37 0.00 (0.00%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Supernus Pharmaceuticals (NASDAQ:SUPN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$13.72M Get SUPN Insider Trade Alerts Want to know when executives and insiders are buying or selling Supernus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SUPN Insider Buying and Selling by Quarter Supernus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/25/2025Frank MottolaSVPSell14,000$44.51$623,140.00 8/25/2025Jack A KhattarCEOSell1,000$45.00$45,000.00 8/22/2025Timothy C DecCFOSell11,780$44.49$524,092.20 8/14/2025Bethany SensenigDirectorSell5,369$42.25$226,840.25 8/14/2025Frederick M HudsonDirectorSell7,457$42.26$315,132.82 8/6/2025Jack A KhattarCEOSell140,000$42.02$5,882,800.00 3/24/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$32.70$1,001 - $15,0002/21/2025Jonathan RubinSVPSell927$39.15$36,292.05 2/4/2025Padmanabh P BhattVPSell9,477$39.70$376,236.90 1/28/2025Padmanabh P BhattVPSell700$39.62$27,734.00 11/7/2024Frank MottolaSVPSell15,000$36.98$554,700.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/7/2024Georges GemayelDirectorSell14,213$36.62$520,480.06 11/7/2024Jack A KhattarCEOSell125,000$36.68$4,585,000.00 (Data available from 1/1/2013 forward) SUPN Insider Trading Activity - Frequently Asked Questions Who is on Supernus Pharmaceuticals' Insider Roster? The list of insiders at Supernus Pharmaceuticals includes Bethany Sensenig, Frank Mottola, Frederick M Hudson, Georges Gemayel, Jack A Khattar, Jonathan Rubin, Padmanabh P Bhatt, Tami Tillotson Martin, and Timothy C Dec. Learn more on insiders at SUPN. What percentage of Supernus Pharmaceuticals stock is owned by insiders? 8.80% of Supernus Pharmaceuticals stock is owned by insiders. Learn more on SUPN's insider holdings. Which Supernus Pharmaceuticals insiders have been selling company stock? The following insiders have sold SUPN shares in the last 24 months: Bethany Sensenig ($226,840.25), Frank Mottola ($1,209,064.30), Frederick M Hudson ($574,283.32), Georges Gemayel ($520,480.06), Jack A Khattar ($10,512,800.00), Jonathan Rubin ($36,292.05), Padmanabh P Bhatt ($1,631,404.11), Tami Tillotson Martin ($482,480.00), and Timothy C Dec ($524,092.20). How much insider selling is happening at Supernus Pharmaceuticals? Insiders have sold a total of 406,965 Supernus Pharmaceuticals shares in the last 24 months for a total of $15,717,736.29 sold. Which members of congress are trading Supernus Pharmaceuticals? Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Supernus Pharmaceuticals in the last year totaling $8,000. Supernus Pharmaceuticals Key ExecutivesMr. Jack A. Khattar (Age 63)Founder, President, CEO, Secretary & Director Compensation: $1.63M2 recent tradesMr. Timothy C. Dec (Age 65)Senior VP & CFO Compensation: $635.43k1 recent tradesDr. Padmanabh P. Bhatt Ph.D. (Age 67)Chief Scientific Officer & Senior VP of Intellectual Property Compensation: $594.14kMr. Frank Mottola (Age 52)Senior Vice President of Quality, GMP Operations & Information Technology Compensation: $490.87k1 recent tradesDr. Jonathan Rubin M.D. (Age 63)MBA, Senior VP of Research & Development and Chief Medical Officer Compensation: $594.65kMr. Kevin T. Anderson (Age 62)Compliance Officer Dr. Todd Horich M.B.A.Ph.D., Senior Vice President of Marketing & Market AccessMr. Taylor RaifordSenior Vice President of SalesDr. Bryan A. Roecklein Ph.D.Senior Vice President of Corporate DevelopmentMs. Tami T. Martin Esq. (Age 69)R.N., Senior Vice President of Regulatory Affairs Compensation: $508.5k More Insider Trading Tools from MarketBeat Related Companies JAZZ Insider Selling CORT Insider Selling PRGO Insider Selling PCRX Insider Selling NKTR Insider Selling OMER Insider Selling ASMB Insider Selling CPIX Insider Selling LLY Insider Selling JNJ Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:SUPN) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access